Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Adenocarcinoma of the Prostate

NCT00003533 is registered in ClinicalTrials.gov with Burzynski Research Institute as lead sponsor.

NCT NCT00003533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Adenocarcinoma of the Prostate
Lead sponsor
Burzynski Research Institute
Phase
Phase 2
Overall status
Terminated
Start date
February 27, 1996
Completion date
December 31, 1999
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer